Clinical Trial Update: An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects [Phase 3]

View source ↗

Summary

Phase 3 study of ALZ-801 in APOE4/4 individuals with early Alzheimer's disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ALZ-801

Snippet

Sponsor: Alzheon Inc. | Conditions: Early Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-11-10